RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IPIX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

INNOVATION PHARMACEUTICAL stock downgraded from Hold/Accumulate to Sell Candidate after Tuesday trading session.
(Updated on Jul 02, 2024)

Sell candidate since Jul 02, 2024 PDF

No changes to the price of INNOVATION PHARMACEUTICAL stock on the last trading day (Tuesday, 2nd Jul 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0012 to a day high of $0.0012. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IPIX Signals & Forecast

There are mixed signals in the stock today. The INNOVATION PHARMACEUTICAL stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0012 and $0.0013. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, June 07, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for INNOVATION PHARMACEUTICAL stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IPIX) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect INNOVATION PHARMACEUTICAL to open at $0.0012, and during the day (based on 14 day Average True Range), to move between $0.0009 and $0.0015, which gives a possible trading interval of +/-$0.0003 (+/-27.33%) up or down from last closing price. If INNOVATION PHARMACEUTICAL takes out the full calculated possible swing range there will be an estimated 54.67% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0013, some $0.0001 (8.33%) from the current price of $0.0012, our system finds the risk reward not very attractive.

Is INNOVATION PHARMACEUTICAL stock A Buy?

INNOVATION PHARMACEUTICAL holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.635 Sell Candidate Downgraded

Predicted Opening Price for INNOVATION PHARMACEUTICAL of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$0.0012 ( 0%) $0.0012

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IPIX

Fibonacci Support & Resistance Levels

Level Price
R3 0.0012 -
R2 0.0012 -
R1 0.0012 -
Price 0.0012
S1 0.0012 -
S2 0.0012 -
S3 0.0012 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0.0013 8.33%
Price 0.0012
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for INNOVATION PHARMACEUTICAL Stock and on which exchange is it traded?
The symbol for INNOVATION PHARMACEUTICAL is IPIX and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell INNOVATION PHARMACEUTICAL Stock?
INNOVATION PHARMACEUTICAL holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy INNOVATION PHARMACEUTICAL Stock?
INNOVATION PHARMACEUTICAL Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy INNOVATION PHARMACEUTICAL Stock.

What's the current price of INNOVATION PHARMACEUTICAL Stock?
As of the end of day on the Jul 02, 2024, the price of an INNOVATION PHARMACEUTICAL (IPIX) share was $0.0012.

What is the 52-week high and low for INNOVATION PHARMACEUTICAL Stock?
The 52-week high for INNOVATION PHARMACEUTICAL Stock is $0.0210 and the 52-week low is $0.0001.

What is the market capitalization of INNOVATION PHARMACEUTICAL Stock?
As of the Jul 02, 2024, the market capitalization of INNOVATION PHARMACEUTICAL is 616.817K.

When is the next earnings date for INNOVATION PHARMACEUTICAL?
The upcoming earnings date for INNOVATION PHARMACEUTICAL is Sep 26, 2024.
Click to get the best stock tips daily for free!

About INNOVATION PHARMACEUTICAL

INNOVATION PHARMACEUTICAL Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovar... IPIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT